KIG
EW icon

Kessler Investment Group’s Edwards Lifesciences EW Stock Holding History

Kessler Investment Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-73,890
Closed -$2.32M – 93
2017
Q1 		$2.32M Sell
73,890
-1,077
-1% -$33.7K 2.96% 17
2016
Q4 		$2.34M Sell
74,967
-3,573
-5% -$116K 2.81% 20
2016
Q3 		$3.16M Buy
78,540
+4,578
+6% +$172K 4.57% 4
2016
Q2 		$2.46M Buy
73,962
+6,129
+9% +$210K 3.52% 11
2016
Q1 		$2M Buy
+67,833
New +$1.87M 3.02% 16

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Kessler Investment Group's EW Position: Q2 2017 in Review

Kessler Investment Group sold out of Edwards Lifesciences (EW) in Q2 2017, closing a stake of 73,890 shares — an estimated $2.32M sold.

Kessler Investment Group first reported a position in EW in Q1 2016 and held it in 5 quarters. The position peaked at $3.16M in Q3 2016. 720 funds tracked by Wall St. Rank hold EW as of Q2 2017.

  • Kessler Investment Group reported no remaining Edwards Lifesciences position as of Q2 2017 after selling out during the quarter.
  • Kessler Investment Group sold 73,890 Edwards Lifesciences shares in Q2 2017, an estimated $2.32M.
  • Kessler Investment Group first reported a position in Edwards Lifesciences in Q1 2016 and held it in 5 quarters.
  • Kessler Investment Group's Edwards Lifesciences position peaked at $3.16M in Q3 2016.
  • 720 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.

Based on Kessler Investment Group's 13F filing for Q2 2017, filed 19 Jul 2017.